Sanofi’s “new chapter” will involve job cuts and scrapping several oncology research projects, a spokesperson confirmed to Endpoints News on Friday.
The pharma giant is conducting a “full pipeline reprioritization project,” according to an internal email obtained by Fierce Biotech. Sanofi declined a request by Endpoints to explain which programs are being cut, how many jobs will be affected or when the changes will occur.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.